Attached files
file | filename |
---|---|
10-Q - 10-Q - Evofem Biosciences, Inc. | neot-10q_20150930.htm |
EX-32.2 - EX-32.2 - Evofem Biosciences, Inc. | neot-ex322_9.htm |
EX-31.1 - EX-31.1 - Evofem Biosciences, Inc. | neot-ex311_7.htm |
EX-31.2 - EX-31.2 - Evofem Biosciences, Inc. | neot-ex312_8.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Neothetics, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
Date: November 12, 2015 |
|
By: |
/s/ George W. Mahaffey |
|
|
|
George W. Mahaffey |
|
|
|
President and Chief Executive Officer (Principal Executive Officer) |
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate document.